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ABSTRACT 
Versatile methodology for the asymmetric synthesis of chiral �-lactones containing four contiguous stereocentres 
has been developed that relies on a series of Evans’ aldol, hydroxyl-directed cyclopropanation and Hg(II)-mediated 
cyclopropane ring-opening reactions for stereocontrol. 
The δ-lactone functional group appears as a fragment in 
many natural products that exhibit a wide range of 
1
biological activity. Many of these structurally complex δ­
lactones contain multiple contiguous stereocentres, which 
means that their asymmetric synthesis can represent a 
2
significant challenge. Consequently, a wide range of 
3
methodology has been developed for their synthesis, with 
chiral N-acyl-oxazolidin-2-ones having often been used to 
prepare �-lactones as intermediates for natural product 
synthesis. These protocols are generally based on the 
stereoselective addition of enolates of chiral N-acyl­
4
oxazolidin-2-ones to enantiopure electrophiles, or 
stereoselective aldol reactions of chiral �-keto-N-acyl­
5
oxazolidin-2-ones enolates. We now report herein an 
alternative strategy that employs a chiral N-acyl­
oxazolidin-2-one to prepare enantiomerically pure 
cyclopropane-esters that undergo regioselective Hg(II) 
ring-opening reactions to afford �-lactones containing 
four contiguous stereocentres with excellent levels of 
stereocontrol. 
We have recently reported the development of novel 
synthetic strategies that employ the reversible generation 
of “temporary stereocentres” for the asymmetric synthesis 
6
of chiral aldehydes. One of these protocols employs 
highly diastereoselective hydroxyl-directed syn-cyclo­
propanation reactions of �-alkenyl-�-hydroxyl-N-acyl­
oxazolidin-2-ones 1 as a key reaction (Scheme 1, reaction 
1) for the asymmetric synthesis of chiral cyclopropane 
7
carboxaldehydes. It has been reported that treatment of �­
cyclopropyl carboxylic acid derivatives such as 3 with 
Hg(II) salts results in regioselective cyclopropane ring-
opening to afford δ-lactones such as 4 (Scheme 1, reaction 
8
2). We have also reported that treatment of �-alkenyl-� ­
hydroxy-N-acyloxazolidin-2-ones with VO(acac)2 and 
tert-butyl hydroperoxide results in formation of unstable 
epoxides 5, which are ring-opened by intramolecular 
nucleophilic attack of their exocyclic carbonyl fragments 
to afford hydroxy-γ-butyrolactones 6 (Scheme 1, reaction 
9
3). Consequently, it was decided to investigate whether 
treatment of �-cyclopropyl-�-hydroxyl-N-acyl-oxazolidin­
2-ones 2 with a Hg(II) species would result in 
regioselective intramolecular ring-opening of their 
cyclopropane rings to afford chiral �-lactones containing 
four contiguous stereocentres. 
Scheme 1. Synthesis and ring-opening reactions of a range of Scheme 2. Treatment of cyclopropane-aldol 2a with 
chiral cyclopropanes and epoxides Hg(OCOCF3)2 results in intramolecular cyclopropane ring-
opening and dehydration to afford �,�-unsaturated lactone 9 
A series of (syn)- and (anti)-aldols 1a-h were prepared 
via literature procedures, involving reaction of boron or 
magnesium enolates of 5,5-dimethyl-N-acyl-oxazolidin-2­
10 
ones 8a/b with their corresponding �,�-unsaturated 
11
aldehydes (Table 1). These aldols 1a-h were then 
cyclopropanated via treatment with Et2Zn and CH2I2 to 
12
afford cyclopropyl-aldols 2a-h in >95% de (Table 1).
Treatment of cyclopropyl-aldol 2a with one equivalent of 
Hg(OCOCF3)2 in CH2Cl2 resulted in regioselective ring-
opening of the cyclopropane ring to afford a 50:50 
mixture of the organomercurial �,�-unsaturated lactone 9 
and the parent oxazolidin-2-one 7 (Scheme 2). It is 
proposed that coordination of Hg(II) to the cyclopropane 
ring of 2a facilitates intramolecular nucleophilic attack by 
the endocyclic carbonyl group, resulting in regioselective 
ring-opening of the cyclopropane ring. This affords an 
iminium species 10 that undergoes a rapid E1cB 
elimination reaction to afford �,�-unsaturated lactone 9 
(Scheme 2). 
Since oxymercuration of �-cyclopropyl-�-hydroxy-N­
acyl-oxazolidin-2-one 2a had resulted in the loss of two 
stereocentres, we decided to investigate oxymercuration 
of its corresponding methyl ester 11a, with the aim of 
isolating a �-lactone 12a retaining all four stereocentres. 
Therefore, treatment of cyclopropyl-aldol 2a with sodium 
methoxide gave ester 11a that was subsequently treated 
with Hg(OCOCF3)2 to afford the desired �-lactone 12a in 
8d
good yield (Scheme 3). Reductive demercuration of �­
lactone 12a via treatment with a solution of NaBH4 in 
aqueous NaOH/MeOH 
resulted in �-lactone 14a, whose absolute configuration 
was confirmed by X-ray-crystallography which clearly 
showed the (3S,4R,5R,6R�-�configuration of its four 
contiguous stereocentres (Figure 1). It is proposed that the 
oxymercuration reaction of ester 11a proceeds via a 
different mechanism to 2a involving nucleophilic attack 
of the trifluoroacetate counterion at its cyclopropane ring 
to afford intermediate 13, which is hydrolysed upon work­
13 
up to afford the observed �-lactone 12a (Scheme 3).
This occurs because the ester group of 11a is a poorer 
nucleophile than the corresponding N-acyl-oxazolidin-2­
one fragment of 2a and therefore less likely to participate 
as an anchimeric nucleophile to facilitate intramolecular 
cyclopropane ring-opening. 
In order to demonstrate the scope and limitation of this 
methodology, the remaining cyclopropyl aldols 2b-h were 
converted into their corresponding methyl esters 11b-h 
and subjected to oxymercuration/reductive demercuration 
to afford a series of �-lactones 14b-h in >95% de (Table 
1). Access to �-lactone 14g is particularly noteworthy 
lactone 14a 
Figure 1. X-ray crystal structure of (3S,4R,5R,6R�-�­
since its terminal O-benzyl group will enable it to function (syn)-(syn)-(anti)-stereotetrad fragments into analogues of 
14

as a bifunctional chiral building block for introducing numerous polyketide natural products.  
 
 
 
 
 
 
Table 3. Asymmetric synthesis of chiral �-lactones containing four contiguous stereocentres 
entry aldol 1a-ha cyclopropane ester 11a-hb 
�-lactone 14a-ha 
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615 

  
 
716
 
  
 
817
 
  
 
a Isolated yields. b Isolated yields over two steps. 
 
 
Scheme 3. Treatment of methyl ester 11a with Hg(OCOCF3)2 
results in intramolecular cyclopropane ring-opening to afford �­
lactone 12a 
Scheme 4 Asymmetric synthesis of (+)-Prelactone B 
We have used this methodology to prepare (+)-
Prelactone B 15, which is a highly functionalised δ­
lactone that has been isolated as a shunt metabolite of 
polyketide metabolism from the baﬁlomycin-producing 
organism Streptomyces griseus.18 Therefore, the boron 
enolate of �-chloropropionyl-N-acyl-oxaolidin-2-one 8c 
was reacted with (E)-4-methylpent-2-enal to afford (syn)­
aldol 16, which was converted into cyclopropyl-ester 17 
via a series of cyclopropanation, dechlorination19 and 
methanolysis reactions. Subsequent treatment of 17 with 
Hg(OCOCF3)2/NaCl(aq), followed by reductive 
demercuration with alkaline NaBH4, resulted in formation 
20

of (+)-Prelactone B 15 in >95% de.
In conclusion, we have developed versatile 
methodology for the asymmetric synthesis of chiral �­
lactones containing four contiguous stereocentres. This 
approach relies on a combination of Evans’ aldol, cyclo­
propanation and Hg(II)-mediated cyclopropane ring-
opening reactions for stereocontrol, with its utility having 
been demonstrated for the asymmetric synthesis of (+)-
Prelactone B. 
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